Literature DB >> 6176486

Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.

R Crainic, P Couillin, N Cabau, A Boue, F Horodniceanu.   

Abstract

Hybridomas secreting neutralizing monoclonal antibodies (MA) against type 1 poliovirus were developed by fusion of mouse myeloma cells with splenocytes of immunized mice. Strain-specific MA selected for their capacity to neutralize wild (Mahoney) or attenuated (Sabin, LSc 2ab) poliovirus strains were used for identification of field isolates. A simple and reliable neutralization-index-assay was developed and used to test for intratypic serodifferentiation of poliovirus with the selected MA. Three subtype classes of type 1 poliovirus have so far been identified by testing 4 reference strains and 96 field isolates: Mahoney-like, LSc-like, and strains not recognized by either anti-Mahoney or anti-LSc MA. Neutralizing MA proved an excellent tool for unequivocal antigenic characterization of different poliovirus strains.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6176486

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  7 in total

1.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

2.  Structural analysis of hepatitis B surface antigen by monoclonal antibodies.

Authors:  E Ben-Porath; J R Wands; R A Marciniak; M A Wong; L Hornstein; R Ryder; M Canlas; A Lingao; K J Isselbacher
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.

Authors:  E A Emini; P Ostapchuk; E Wimmer
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

4.  Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.

Authors:  E A Emini; S Y Kao; A J Lewis; R Crainic; E Wimmer
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

5.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

6.  Oral poliovirus vaccine in tropical Africa: greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates.

Authors:  D L Heymann; K Murphy; M Brigaud; M Aymard; A Tembon; G K Maben
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 7.  The application of monoclonal antibodies in the study of viruses.

Authors:  M J Carter; V ter Meulen
Journal:  Adv Virus Res       Date:  1984       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.